4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-21-023086
Chief Business Officer acquired 4,330 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Beaurang Pierre · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-25 | Exercise or conversion : show line 1 in the form | +4,330 | $0.84 | $3,637 | 4,330 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-25 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −4,330 | $0.84 | 2026-01-27 | 4,330 | 2,396 | D |
Loading xslF345X03/doc4.xml…